Study Links Serotonin Deficiency to Depression

A new study provides the first direct evidence that diminished 5-HT release confirms the “serotonin hypothesis.”

Screen Shot 2022 04 18 At 2 41 24 Pm
Getty Images

Depression is one of the most common mental illnesses, and for more than half a century it has been linked to disruptions in the serotonin neurotransmitter system. However, the evidence to support that link has been indirect, leading researchers in the field to request a reexamination of the “serotonin hypothesis.” Only about half of patients respond to antidepressants, and less than 30% see total remission. According to a recent SciTechDaily article, a new study, published in the journal Biological Psychiatry,  has finally made a direct link. 

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report